CNBC: Gilead gets emergency FDA authorization for remdesivir to treat coronavirus
The Food and Drug Administration has granted emergency use authorization for Gilead’s remdesivir drug to treat the coronavirus, President Trump said.
This is the most hopeful drug news yet in the fight against coronavirus.
Gilead’s investigational antiviral for the treatment of COVID-19 receives @US_FDA Emergency Use Authorization. This more readily enables treatment of hospitalized patients with severe COVID-19 disease in the United States. Read more: https://t.co/p4LR0RM7sI. pic.twitter.com/4kg9oDQPRq
— Gilead Sciences (@GileadSciences) May 1, 2020
